07:00 , Oct 5, 2015 |  BC Week In Review  |  Company News

BioQuiddity, Lee’s Pharmaceutical Holdings Ltd. deal

BioQuiddity granted Lee’s Pharmaceutical rights to commercialize ropivacaine and propofol infusion products in Taiwan and China, including Hong Kong and Macau. The products are single-use, unit-dose infusible products comprising the drug and a delivery system....